Premenopausal women would benefit from a significantly more accurate diagnostic pathway for ovarian cancer, as a new study ...

In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a ...

Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of medical tests that contribute to health ...

FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive first-line Keytruda. The U.S. Food and Drug Administration (FDA) has ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It's the latest example of medical tests that contribute to health ...

BOSTON and ROLLE, Switzerland and MADRID, Feb. 7, 2024 /PRNewswire/ -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it has expanded an ...

A new Ovarian Cancer Foundation report shows almost half of all women in New Zealand with the disease, are being diagnosed in emergency departments. Overall about 85 percent of women with ovarian ...